Geneos Wealth Management Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6282000.0%0.00%
Q3 2022$02000.0%0.00%
Q2 2022$0
-100.0%
2000.0%0.00%
Q1 2022$1,0000.0%2000.0%0.00%
Q4 2021$1,0000.0%2000.0%0.00%
Q3 2021$1,000
-50.0%
2000.0%0.00%
Q2 2021$2,0000.0%2000.0%0.00%
Q1 2021$2,0000.0%2000.0%0.00%
Q4 2020$2,000
+100.0%
2000.0%0.00%
Q3 2020$1,0000.0%2000.0%0.00%
Q2 2020$1,0000.0%2000.0%0.00%
Q1 2020$1,0000.0%2000.0%0.00%
Q4 2019$1,0000.0%2000.0%0.00%
Q3 2019$1,000
-50.0%
2000.0%0.00%
Q2 2019$2,000
-75.0%
200
-60.0%
0.00%
-100.0%
Q3 2018$8,000
-61.9%
500
-66.7%
0.00%
-50.0%
Q2 2018$21,000
-8.7%
1,500
+20.1%
0.00%0.0%
Q1 2018$23,000
-48.9%
1,249
-54.9%
0.00%
-50.0%
Q4 2017$45,000
+2.3%
2,769
-6.6%
0.00%0.0%
Q3 2017$44,0002,9650.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders